Development and validation of thromboembolism diagnostic algorithms in children with cancer from real-world data.
Journal
Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714
Informations de publication
Date de publication:
22 Feb 2024
22 Feb 2024
Historique:
received:
15
10
2023
accepted:
21
01
2024
revised:
03
01
2024
medline:
23
2
2024
pubmed:
23
2
2024
entrez:
22
2
2024
Statut:
aheadofprint
Résumé
To evaluate the accuracy of diagnostic algorithms developed using the International Classification of Diseases (ICD-9-CM and ICD-10-CA) diagnostic codes and physician billing codes for thromboembolism (TE) from health administrative data compared to chart review diagnoses of TE in children with cancer. Using data linkage between the Pediatric Oncology Group of Ontario Network Information System (Ontario pediatric cancer registry) and various administrative data housed at ICES, eight algorithms were developed including a single reference to one of the billing codes, multiple references with varying time intervals, and combinations of various billing codes during primary cancer therapy for the whole cohort and, for early (<04/2002) and later (≥04/2002, solely ICD-10 codes) periods. Reference standard was chart review data from prior studies (from 1990 to 2016) among children (≤19 years) with cancer and radiologically confirmed TE. Records of 2056 patients diagnosed with cancer at two participating sites during study period were reviewed; 112 had radiologically confirmed TE. The algorithm with addition of anticoagulation utilization codes was the best performing algorithm (sensitivity = 0.76;specificity = 0.85). With use of ICD-10 only codes, sensitivity of the same algorithm improved to 0.84 with specificity of 0.80. This study provides a valid approach for ascertaining pediatric TE using real-world data. Research in pediatric thrombosis, especially cancer-related thrombosis, is limited mainly due to small-sized studies. Real-world data provide ready access to large and diverse populations. However, there are no validated algorithms for identifying thrombosis in real-world data for children. An algorithm based on combination of thrombosis and anticoagulation utilization codes had 76% sensitivity and 85% specificity to identify diagnosis of thrombosis in children in administrative data. This study provides a valid approach for ascertaining pediatric thrombosis using real-world data and offers a good avenue to advance pediatric thrombosis research.
Identifiants
pubmed: 38388822
doi: 10.1038/s41390-024-03082-x
pii: 10.1038/s41390-024-03082-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.
Références
Raffini, L., Huang, Y.-S., Witmer, C. & Feudtner, C. Dramatic increase in venous thromboembolism in U.S. Children’s Hospitals from 2001–2007. Pediatrics 124, 1001–1008 (2009).
doi: 10.1542/peds.2009-0768
pubmed: 19736261
O’Brien, S. H., Klima, J., Termuhlen, A. M. & Kelleher, K. J. Venous thromboembolism and adolescent and young adult oncology inpatients in US Children’s Hospitals, 2001 to 2008. J. Pediatr. 159, 133–137 (2011).
doi: 10.1016/j.jpeds.2011.01.005
pubmed: 21353248
Pelland-Marcotte, M.-C. et al. Thromboembolism incidence and risk factors in children with cancer: a population-based cohort study. Thromb. Haemost. 118, 1646–1655 (2018).
doi: 10.1055/s-0038-1668543
pubmed: 30103249
Athale, U. Thrombosis in pediatric cancer: identifying the risk factors to improve care. Expert Rev. Hematol. 6, 599–609 (2013).
doi: 10.1586/17474086.2013.842124
pubmed: 24125523
Ranta, S. et al. Cerebro-sinovenous thrombosis in children with acute lymphoblastic leukemia- a multicenter study from nordic pediatric hematology oncology. Br. J. Haematol. 168, 547–552 (2015).
doi: 10.1111/bjh.13162
pubmed: 25288392
Tuckuviene, R. et al. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study. J. Thromb. Haemost. 14, 485–494 (2016).
doi: 10.1111/jth.13236
pubmed: 26707629
Caruso, V. et al. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 patients. Blood 108, 2216–2222 (2006).
doi: 10.1182/blood-2006-04-015511
pubmed: 16804111
Mitchell, L. G. et al. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase. Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) study. Cancer 97, 508–516 (2003).
doi: 10.1002/cncr.11042
pubmed: 12518376
Paz-Priel, I., Long, L., Helman, L. J., Mackall, C. L. & Wayne, A. S. Thromboembolic events in children and young adults with pediatric sarcoma. J. Clin. Oncol. 25, 1519–1524 (2007).
doi: 10.1200/JCO.2006.06.9930
pubmed: 17442994
Grace, R. F. et al. The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols. Br. J. Haematol. 152, 452–459 (2011).
doi: 10.1111/j.1365-2141.2010.08524.x
pubmed: 21210774
pmcid: 5763913
Athale, U. et al. Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: results from Dana-Farber Cancer Institute ALL Consortium trial 05-001. Pediatr. Blood Cancer 69, e29581 (2022).
doi: 10.1002/pbc.29581
pubmed: 35316569
Setty, B. A., O’Brien, S. H. & Kerlin, B. A. Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases. Pediatr. Blood Cancer 59, 258–264 (2012).
doi: 10.1002/pbc.23388
pubmed: 22038730
Forbrigger, Z. et al. The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study. Ann. Hematol. 97, 1903–1908 (2018).
doi: 10.1007/s00277-018-3371-0
pubmed: 29846760
Kulkarni, K. et al. Increased requirement for central venous catheter replacement in paediatric oncology patients with deep venous thrombosis: a multicentre study. Thromb. Haemost. 113, 434–435 (2015).
doi: 10.1160/TH14-07-0626
pubmed: 25273363
Journeycake, J. M. & Buchanan, G. R. Catheter-related deep venous thrombosis and other catheter complications in children with cancer. J. Clin. Oncol. 28, 4575–4580 (2006).
doi: 10.1200/JCO.2005.05.5343
Pelland-Marcotte, M. C. et al. Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: a report from CYP-C. Am. J. Hematol. 96, 796–804 (2021).
doi: 10.1002/ajh.26193
pubmed: 33848369
Doiron, D., Raina, P. & Fortier, I. Linking Canadian population health data: maximizing the potential of cohort and administrative data. Can. J. Public Health 104, e258–e261 (2013).
doi: 10.17269/cjph.104.3775
pubmed: 23823892
pmcid: 3880355
Ulrich, E. H., So, G., Zappitelli, M. & Chanchlani, R. A review on the application and limitations of administrative health care data for the study of acute kidney injury epidemiology and outcomes in children. Front. Pediatr. 9, 742888 (2021).
doi: 10.3389/fped.2021.742888
pubmed: 34778133
pmcid: 8578942
Burles, K., Innes, G., Senior, K., Lang, E. & McRae, A. Limitations of pulmonary embolism ICD-10 codes in emergency department administrative data: let the buyer beware. BMC Med. Res. Methodol. 17, 89 (2017).
doi: 10.1186/s12874-017-0361-1
pubmed: 28595574
pmcid: 5465555
Alotaibi, G. S., Wu, C., Senthilselvan, A. & McMurtry, M. S. The validity of ICD codes coupled with imaging procedure codes for identifying acute venous thromboembolism using administrative data. Vasc. Med. 20, 364–368 (2015).
doi: 10.1177/1358863X15573839
pubmed: 25834115
Tamariz, L., Harkins, T. & Nair, V. A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data. Pharmacoepidemiol. Drug Saf. 21, 154–162 (2021).
doi: 10.1002/pds.2341
Branchford, B. R., Gibson, E., Manco-Johnson, M. J. & Goldenberg, N. A. Sensitivity of discharge diagnosis ICD-9 codes for pediatric venous thromboembolism is greater than specificity, but still suboptimal for surveillance and clinical research. Thromb. Res. 129, 662–663 (2012).
doi: 10.1016/j.thromres.2011.10.032
pubmed: 22104422
https://www.pogo.ca/wp-content/uploads/2015/02/POGO_CC-Atlas-2-POGONIS_Feb-2015.pdf , accessed 7 April 2023.
https://www.ices.on.ca/Data-and-Privacy/ICES-data , accessed 7 April 2023.
Greenberg, M. L. et al. Childhood cancer registries in Ontario, Canada: lessons learned from a comparison of two registries. Int. J. Cancer 105, 88–91 (2003).
doi: 10.1002/ijc.11004
pubmed: 12672035
Pole, J. D. et al. Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT. Bone Marrow Transpl. 50, 721–726 (2015).
doi: 10.1038/bmt.2015.4
Pole, J. D., Gu, L. Y., Kirsh, V., Greenberg, M. L. & Nathan, P. C. Subsequent malignant neoplasms in a population-based cohort of pediatric cancer patients: a focus on the first 5 years. Cancer Epidemiol. Biomark. Prev. 24, 1585–1592 (2015).
doi: 10.1158/1055-9965.EPI-15-0360
Gupta, S. et al. Validity of administrative data in identifying cancer-related events in adolescents and young adults. Med. Care 56, e32–e38 (2018).
doi: 10.1097/MLR.0000000000000777
pubmed: 28731893
Athale, U. H. et al. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr. Blood Cancer 51, 792–797 (2008).
doi: 10.1002/pbc.21734
pubmed: 18798556
Spavor, M. et al. Age at cancer diagnosis, non-O blood group and asparaginase therapy are independently associated with deep venous thrombosis in pediatric oncology patients: a risk model. Thromb. Res. 144, 27–31 (2016).
doi: 10.1016/j.thromres.2016.05.015
pubmed: 27270219
Halton, J. et al. Do children with central venous line dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy? Study protocol. BMC Cancer 12, 314 (2012).
doi: 10.1186/1471-2407-12-314
pubmed: 22835078
pmcid: 3502590
Steliarova-Foucher, E., Stiller, C., Lacour, B. & Kaatsch, P. International classification of childhood cancer, third edition. Cancer 103, 1457–1467 (2005).
doi: 10.1002/cncr.20910
pubmed: 15712273
Walker, A. J. et al. Venous thromboembolism in children with cancer- a population-based cohort study. Thromb. Res. 133, 340–344 (2014).
doi: 10.1016/j.thromres.2013.12.021
pubmed: 24388573
pmcid: 3969718
Delate, T. et al. Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist 17, 419–427 (2012).
doi: 10.1634/theoncologist.2011-0323
pubmed: 22334451
pmcid: 3316928
Molnar, A. O. et al. Risk and complications of venous thromboembolism in dialysis patients. Nephrol. Dial. Transpl. 33, 874–880 (2018).
Bujang, M. A. & Adnan, T. H. Requirements for minimum sample size for sensitivity and specificity analysis. J. Clin. Diagn. Res. 10, YE01–YE06 (2016).
pubmed: 27891446
pmcid: 5121784
Fang, M. C. et al. Validity of using inpatient and outpatient administrative codes to identify acute venous thromboembolism: the CVRN VTE study. Med. Care 55, e137–e143 (2017).
doi: 10.1097/MLR.0000000000000524
pubmed: 29135777
pmcid: 5125903
Quan, H. et al. IMECCHI investigators. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv. Res. 43, 1424–1441 (2008).
doi: 10.1111/j.1475-6773.2007.00822.x
pubmed: 18756617
pmcid: 2517283
Monaghan, T. F. et al. Foundational statistical principles in medical research: sensitivity, specificity, positive predictive value, and negative predictive value. Medicine 57, 503 (2021).
Lucyk, K. et al. Administrative health data in Canada: lessons from history. BMC Med. Inf. Decis. Mak. 15, 69–74 (2015).
doi: 10.1186/s12911-015-0196-9